Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.
about
Imaging of anticancer drug action in single cells.Multiple Administrations of Viral Nanoparticles Alter in Vivo Behavior-Insights from Intravital Microscopy.Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological Modeling.Hydrophobic Effect from Conjugated Chemicals or Drugs on In Vivo Biodistribution of RNA Nanoparticles.
P2860
Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor Targeting and Pharmacoki ...... Antagonist Agent, Dmt-Tic-Cy5.
@en
Tumor Targeting and Pharmacoki ...... Antagonist Agent, Dmt-Tic-Cy5.
@nl
type
label
Tumor Targeting and Pharmacoki ...... Antagonist Agent, Dmt-Tic-Cy5.
@en
Tumor Targeting and Pharmacoki ...... Antagonist Agent, Dmt-Tic-Cy5.
@nl
prefLabel
Tumor Targeting and Pharmacoki ...... Antagonist Agent, Dmt-Tic-Cy5.
@en
Tumor Targeting and Pharmacoki ...... Antagonist Agent, Dmt-Tic-Cy5.
@nl
P2093
P2860
P1476
Tumor Targeting and Pharmacoki ...... Antagonist Agent, Dmt-Tic-Cy5.
@en
P2093
Allison S Cohen
Amanda Shanks Huynh
David L Morse
Jongphil Kim
Josef Vagner
Joseph Johnson
Mark C Lloyd
Tingan Chen
Todd J Casagni
Valerie E Stark
P2860
P304
P356
10.1021/ACS.MOLPHARMACEUT.5B00760
P407
P577
2015-12-29T00:00:00Z